Zhang, Bessie X.
Brantley, Kristen D.
Rosenberg, Shoshana M.
Kirkner, Gregory J.
Collins, Laura C.
Ruddy, Kathryn J.
Tamimi, Rulla M.
Schapira, Lidia
Borges, Virginia F.
Warner, Ellen
Come, Steven E.
Winer, Eric P.
Bellon, Jennifer R.
Partridge, Ann H.
Funding for this research was provided by:
Susan G. Komen
Breast Cancer Research Foundation
Article History
Received: 1 April 2024
Accepted: 7 June 2024
First Online: 10 June 2024
Declarations
:
: SMR reports grant support from Pfizer Global Medical Grants/Conquer Cancer. VFB reports research funds (paid to institution) from Gilead, SeaGen, AstraZeneca, and Olema; consulting fees from Gilead, SeaGen, and AstraZeneca; and stock ownership in/founder of PEARL Scientific. AHP reports research support from Novartis for medical writing (not related to this manuscript); and royalties for authorship from Wolters Kluwer. All other authors have no competing interests to declare.
: The YWS was approved by the Institutional Review Board at the Dana-Farber/Harvard Cancer Center and other participating sites.
: Informed consent was obtained from all individual participants included in the study.